We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $160M
1-Year Est. Return 8.57%
This Fund
S&P 500
This Quarter Est. Return
+15.98%
1 Year Est. Return
+8.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
+$15.4M
Cap. Flow
+$1.25M
Cap. Flow %
0.88%
Top 10 Hldgs %
49.55%
Holding
52
New
6
Increased
14
Reduced
22
Closed
7

Top Buys

Rank Stock Value
1
SLDB icon
Solid Biosciences
SLDB
+$3.84M
2
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$2.35M
3
ATNX
Athenex, Inc. Common Stock
ATNX
+$2.3M
4
ARGX icon
argenx
ARGX
+$2.21M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$2.19M

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.33M
2
XLRN
Acceleron Pharma
XLRN
+$1.98M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$1.84M
4
IMMU
Immunomedics Inc
IMMU
+$1.76M
5
AWI icon
Armstrong World Industries
AWI
+$1.66M

Sector Composition

Rank Sector Weight
1 Healthcare 52.79%
2 Financials 31.36%
3 Consumer Discretionary 8.42%
4 Industrials 2.47%
5 Technology 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
26
Madrigal Pharmaceuticals
MDGL
$11.7B
$2.21M 1.55%
17,632
+594
+3% +$73.8K
IOVA icon
27
Iovance Biotherapeutics
IOVA
$2.95B
$2.2M 1.54%
230,892
-16,750
-7% -$163K
RYTM icon
28
Rhythm Pharmaceuticals
RYTM
$7.99B
$2.18M 1.53%
79,398
-3,369
-4% -$96.8K
BCRX icon
29
BioCryst Pharmaceuticals
BCRX
$2.51B
$2.16M 1.52%
265,013
-52,732
-17% -$451K
ARNA
30
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2.14M 1.51%
+47,779
New +$2.19M
HRTX icon
31
Heron Therapeutics
HRTX
$63.5M
$2.11M 1.49%
86,477
+2,212
+3% +$57.9K
STX icon
32
Seagate
STX
$209B
$2.02M 1.42%
42,219
-1,444
-3% -$64.1K
GHDX
33
DELISTED
Genomic Health, Inc.
GHDX
$2M 1.41%
28,619
-1,700
-6% -$126K
BFH icon
34
Bread Financial
BFH
$4.51B
$1.95M 1.37%
13,961
+2,046
+17% +$279K
MS icon
35
Morgan Stanley
MS
$343B
$1.94M 1.36%
45,964
+3,221
+8% +$136K
KKR icon
36
KKR & Co
KKR
$103B
$1.93M 1.35%
82,041
-3,900
-5% -$88.8K
CBRE icon
37
CBRE Group
CBRE
$44B
$1.91M 1.34%
38,566
-4,966
-11% -$233K
ACA icon
38
Arcosa
ACA
$7.12B
$1.87M 1.32%
+61,342
New +$1.87M
BHC icon
39
Bausch Health
BHC
$2.37B
$1.87M 1.32%
75,828
+2,299
+3% +$54.9K
C icon
40
Citigroup
C
$233B
$1.87M 1.31%
30,027
+932
+3% +$57.9K
SLM icon
41
SLM Corp
SLM
$5.22B
$1.69M 1.18%
170,029
-9,104
-5% -$94.2K
TRN icon
42
Trinity Industries
TRN
$2.34B
$1.65M 1.16%
75,769
-5,970
-7% -$136K
SMC
43
Summit Midstream
SMC
$480M
$852K 0.6%
5,837
– –
COCP icon
44
Cocrystal Pharma
COCP
$15.2M
$417K 0.29%
12,743
– –
SPY icon
45
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$266K 0.19%
942
+70
+8% +$19K
ALNY icon
46
Alnylam Pharmaceuticals
ALNY
$30.4B
– –
-31,959
Closed -$2.33M
AMZN icon
47
Amazon
AMZN
$2.86T
– –
-3,160
Closed -$237K
AWI icon
48
Armstrong World Industries
AWI
$7.68B
– –
-28,514
Closed -$1.66M
DRNA
49
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-172,524
Closed -$1.84M
XLRN
50
DELISTED
Acceleron Pharma
XLRN
– –
-45,445
Closed -$1.98M
1
2
3

Similar funds

SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
LCA
Legend Capital Advisors New York $160M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return
BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM

Emory University's Q1 2019 Portfolio in Review

As of Q1 2019, Emory University held 52 positions worth $142M, up 12% from $127M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Emory University's Q1 2019 filing shows 6 new, 14 increased, 22 reduced and 7 closed positions. Its largest new stake was Orchard Therapeutics plc American Depositary Shares: 15,640 shares worth $2.8M. The largest sale was Alnylam Pharmaceuticals, an estimated $2.33M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 48% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Emory University's largest Q1 2019 buy was Orchard Therapeutics plc American Depositary Shares: 15,640 shares worth $2.8M.
  • Emory University added most to Solid Biosciences in Q1 2019, an estimated $3.84M increase.
  • Emory University's biggest Q1 2019 reduction was Global Blood Therapeutics, Inc., cutting an estimated $829K.
  • Emory University fully exited Alnylam Pharmaceuticals in Q1 2019, selling an estimated $2.33M.
  • Emory University's ten largest holdings make up 50% of its $142M portfolio in Q1 2019.
  • Emory University opened 6 new positions and closed 7 in Q1 2019.
  • Emory University's portfolio value rose 12% quarter-over-quarter to $142M.

Based on Emory University's 13F filing for Q1 2019, filed 9 May 2019.